Market Tracker

03/27 5:16pm ET

Novelion Therapeutics Inc (NASDAQ:NVLN)

10.69
Delayed Data
As of 3:59pm ET
 -0.04 / -0.37%
Today’s Change
6.10
Today|||52-Week Range
13.80
+26.96%
Year-to-Date
No recent news for Novelion Therapeutics Inc.

Today’s Trading

Previous close10.73
Today’s open10.60
Day’s range10.55 - 10.75
Volume33,607
Average volume (3 months)100,562
Market cap$198.8M
Dividend yield36.65%
Data as of 3:59pm ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)-450.00%
Earnings growth (this year)-1.14%
Earnings growth (next 5 years)+74.60%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.80

Competitors

 Today’s
change
Today’s
% change
NATRNatures Sunshine Pro...+0.05+0.55%
CTSOCytosorbents Corp+0.13+2.30%
CDTXCidara Therapeutics ...+0.45+6.21%
NUTRNutraceutical Intern...+0.15+0.48%
Data as of 3:59pm ET, 03/27/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$0.00
Annual profit (last year)-$23.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mary J. Szela
Director, Chief Financial &
Administrative Officer
Gregory D. Perry
Corporate headquarters
Vancouver, British Columbia

Forecasts